MedTrace Logo

DeNovo NT Natural Tissue Graft Stratified Knee Study

NCT01670617 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-01-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the long-term relief of pain and return to function for patients receiving DeNovo NT for cartilage lesions in the knee. DeNovo NT is a marketed product and has been used in more than 7,500 patients over the last 7 years.

Conditions

  • Defect of Articular Cartilage
  • Knee Injuries

Interventions

OTHER

Particulated Juvenile Articular Cartilage

Treatment of articular cartilage defects up to 7.5 cm2

Sponsors & Collaborators

  • Zimmer Orthobiologics, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2018-12-31
Completion
2021-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01670617 on ClinicalTrials.gov